Project name: Genomic alteration of histone acetylation associated with TSA treatment in esophageal cancer cells by ChIP-seq

Description: Trichostatin A (TSA) is emerging as a potential component in anticancer therapy. In this study, we aimed to identify the genomic alteration of histone acetylation associated with TSA treatment.ChIP-Seq was performed to find the acetylation sites of histone H3K9 in genome-widely altered by TSA. Differential peak-related genes were found to be associated with TSA treatment, which were identified by ChIP-Seq with specific antibody against acetylated histone H3K9.

Data type: Raw sequence reads; Genome sequencing

Sample scope: Multiisolate

Relevance: Medical

Release date: 2021-02-10

Last updated: 2021-02-19

Data size: 11.16GB